During the past decade, Vince and Associates Clinical Research conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 29 clinical trials were completed, i.e. on average, 78.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vince and Associates Clinical Research" #1 sponsor was "Pfizer" with 21 trials, followed by "Shire" with 9 trials sponsored, "Indivior Inc." with 5 trials sponsored, "National Institute on Drug Abuse (NIDA)" with 5 trials sponsored and "Cephalon" with 5 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vince and Associates Clinical Research" #1 collaborator was "Vince & Associates Clinical Research, Inc." with 3 trials as a collaborator, "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Dyax Corp." with 1 trials as a collaborator, "Food and Drug Administration (FDA)" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Vince and Associates Clinical Research" are "ADHD" (7 trials), "Hypercholesterolemia" (6 trials), "Influenza" (6 trials), "Major Depressive Disorder" (5 trials) and "Opioid Use Disorder" (5 trials). Many other conditions were trialed in "Vince and Associates Clinical Research" in a lesser frequency.

Most popular intervention types in "Vince and Associates Clinical Research" are "Drug" (81 trials), "Biological" (26 trials), "Other" (8 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "placebo" (7 trials), "PF-04950615 (RN316)" (4 trials), "Alprazolam" (3 trials) and "RBP-6000" (3 trials). Other intervention names were less common.

The vast majority of trials in "Vince and Associates Clinical Research" are 105 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Vince and Associates Clinical Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 98 completed trials in Vince and Associates Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vince and Associates Clinical Research, 41 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".